Agenus, Inc. (AGEN)
3.35
+0.28
(+9.12%)
USD |
NASDAQ |
Jun 11, 13:29
Agenus Max Drawdown (5Y) : 98.84% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 98.84% |
| April 30, 2026 | 98.84% |
| March 31, 2026 | 98.84% |
| February 28, 2026 | 98.84% |
| January 31, 2026 | 98.84% |
| December 31, 2025 | 98.84% |
| November 30, 2025 | 98.84% |
| October 31, 2025 | 98.84% |
| September 30, 2025 | 98.84% |
| August 31, 2025 | 98.84% |
| July 31, 2025 | 98.84% |
| June 30, 2025 | 98.84% |
| May 31, 2025 | 98.84% |
| April 30, 2025 | 98.84% |
| March 31, 2025 | 98.84% |
| February 28, 2025 | 98.02% |
| January 31, 2025 | 98.02% |
| December 31, 2024 | 98.02% |
| November 30, 2024 | 98.02% |
| October 31, 2024 | 96.77% |
| September 30, 2024 | 96.48% |
| August 31, 2024 | 96.48% |
| July 31, 2024 | 96.18% |
| June 30, 2024 | 96.18% |
| May 31, 2024 | 96.18% |
| Date | Value |
|---|---|
| April 30, 2024 | 96.18% |
| March 31, 2024 | 91.86% |
| February 29, 2024 | 91.34% |
| January 31, 2024 | 91.34% |
| December 31, 2023 | 90.35% |
| November 30, 2023 | 90.35% |
| October 31, 2023 | 88.40% |
| September 30, 2023 | 83.74% |
| August 31, 2023 | 83.74% |
| July 31, 2023 | 83.74% |
| June 30, 2023 | 83.74% |
| May 31, 2023 | 83.74% |
| April 30, 2023 | 83.74% |
| March 31, 2023 | 83.74% |
| February 28, 2023 | 83.74% |
| January 31, 2023 | 83.74% |
| December 31, 2022 | 83.74% |
| November 30, 2022 | 83.74% |
| October 31, 2022 | 83.74% |
| September 30, 2022 | 83.74% |
| August 31, 2022 | 83.74% |
| July 31, 2022 | 83.74% |
| June 30, 2022 | 83.74% |
| May 31, 2022 | 83.74% |
| April 30, 2022 | 83.74% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Iovance Biotherapeutics, Inc. | 96.84% |
| AnaptysBio, Inc. | 85.45% |
| Amarin Corp. Plc | 98.07% |
| Inovio Pharmaceuticals, Inc. | 99.62% |
| Vertex Pharmaceuticals, Inc. | 41.60% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -67.17 |
| Beta (5Y) | 1.568 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 96.76% |
| Historical Sharpe Ratio (5Y) | -0.5221 |
| Historical Sortino (5Y) | -1.084 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 36.15% |